Publications


ST2/MyD88 Deficiency Protects Mice against Acute Graft-versus-Host Disease and Spares Regulatory T Cells;
Griesenauer, B, Jiang, H, Yang, J, Zhang, J, Ramadan, AM, Egbosiuba, J, Campa, K & Paczesny, S 2019, Journal of immunology (Baltimore, Md. : 1950), vol. 202, no. 10, pp. 3053-3064. https://doi.org/10.4049/jimmunol.1800447

Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease;
Yang, J, Ramadan, A, Reichenbach, DK, Loschi, M, Zhang, J, Griesenauer, B, Liu, H, Hippen, KL, Blazar, BR & Paczesny, S 2019, JCI insight, vol. 4, no. 5. https://doi.org/10.1172/jci.insight.122014

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity;
Chen, H-M, van der Touw, W, Wang, YS, Kang, K, Mai, S, Zhang, J, Alsina-Beauchamp, D, Duty, JA, Mungamuri, SK, Zhang, B, Moran, T, Flavell, R, Aaronson, S, Hu, H-M, Arase, H, Ramanathan, S, Flores, R, Pan, P-Y & Chen, S-H 2018, The Journal of clinical investigation, vol. 128, no. 12, pp. 5647-5662. https://doi.org/10.1172/JCI97570

From proteomics to discovery of first-in-class ST2 inhibitors active in vivo;
Ramadan, AM, Daguindau, E, Rech, JC, Chinnaswamy, K, Zhang, J, Hura, GL, Griesenauer, B, Bolten, Z, Robida, A, Larsen, M, Stuckey, JA, Yang, CY & Paczesny, S 2018, JCI Insight, vol. 3, no. 14. https://doi.org/10.1172/jci.insight.99208

Leukocyte immunoglobulin-like receptors in human diseases: An overview of their distribution, function, and potential application for immunotherapies;
Zhang, J, Mai, S, Chen, H-M, Kang, K, Li, XC, Chen, SH & Pan, PY 2017, Journal of Leukocyte Biology, vol. 102, no. 2, pp. 351-360. https://doi.org/10.1189/jlb.5MR1216-534R

Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function;
Nam, S, Kang, K, Cha, JS, Kim, JW, Lee, HG, Kim, Y, Yang, Y, Lee, MS & Lim, JS 2016, Journal of Leukocyte Biology, vol. 100, no. 6, pp. 1273-1284. https://doi.org/10.1189/jlb.1A0215-068RR

BIM-mediated apoptosis and oncogene addiction;
Li, Y, Deutzmann, A & Felsher, DW 2016, Aging, vol. 8, no. 9, pp. 1834-1835. https://doi.org/10.18632/aging.101072

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards;
Bronte, V, Brandau, S, Chen, S-H, Colombo, MP, Frey, AB, Greten, TF, Mandruzzato, S, Murray, PJ, Ochoa, A, Ostrand-Rosenberg, S, Rodriguez, PC, Sica, A, Umansky, V, Vonderheide, RH & Gabrilovich, DI 2016, Nature communications, vol. 7, 12150. https://doi.org/10.1038/ncomms12150

BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia;
Li, Y, Deutzmann, A, Choi, PS, Fan, AC & Felsher, DW 2016, Oncotarget, vol. 7, no. 19, pp. 26926-26934. https://doi.org/10.18632/oncotarget.8731
Live Chat Available